Chemical Structure (Onzetra 01)
Onzetra Xsail Capsule
Product Images NDC 42847-311
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Onzetra Xsail (NDC 42847-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Currax Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Onzetra 02)
Figure (Onzetra 03)
This is a set of instructions on how to use Onzetra Xsail, a medication delivery device for the nose. The user needs to insert the nosepiece and pierce the medication capsule, then place the nosepiece in their nostril while rotating the device to place the mouthpiece in their mouth. They should blow into the device for a few seconds to deliver the medication into their nose. Then they should check the capsule to see if the medication is gone and discard the used nosepiece. The process should be repeated with the second nosepiece in the other nostril. If there is any residue after use, the user can repeat the steps with the same nosepiece, but if one or both capsules appear unused, they should contact their healthcare provider.*
Principal Display Panel (11 mg Pouch Carton)
ONZETRA Xsail is a prescription medication in the form of sumatriptan nasal powder, with each nosepiece containing 11 mg of the active drug. The medication is intended for intranasal use only and should be stored at room temperature, with no need for refrigeration. A typical dose is 22 mg delivered intranasally, with two reusable blue devices provided for immediate use and as a spare. The medication comes in a package with 16 nosepieces, equal to 8 doses, with two nosepieces per pouch. Before use, patients are advised to read the instructions carefully to ensure proper administration. The medication is distributed by Currax Pharmaceuticals LLC and contains trademarks registered in the United States and other countries.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
